South Africa Oligonucleotide Synthesis Market Size & Outlook
South Africa oligonucleotide synthesis market, 2018-2030 (US$M)
Related Markets
South Africa oligonucleotide synthesis market highlights
- The South Africa oligonucleotide synthesis market generated a revenue of USD 24.1 million in 2024 and is expected to reach USD 42.3 million by 2030.
- The South Africa market is expected to grow at a CAGR of 9.8% from 2025 to 2030.
- In terms of segment, services was the largest revenue generating segment in 2024.
- Services is the most lucrative segment segment registering the fastest growth during the forecast period.
Oligonucleotide synthesis market data book summary
| Market revenue in 2024 | USD 24.1 million |
| Market revenue in 2030 | USD 42.3 million |
| Growth rate | 9.8% (CAGR from 2024 to 2030) |
| Largest segment | Services |
| Fastest growing segment | Services |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oligonucleotides, Equipment/Synthesizer, Reagents, Services |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, GE HealthCare Technologies Inc Common Stock, Agilent Technologies, Kaneka Corp, Heritage Global Inc, Twist Bioscience Corp, Bio-Synthesis, Biolegio |
Other key industry trends
- In terms of revenue, South Africa accounted for 0.6% of the global oligonucleotide synthesis market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia oligonucleotide synthesis market is projected to lead the regional market in terms of revenue in 2030.
- Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 44.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Oligonucleotide Synthesis Market Scope
Oligonucleotide Synthesis Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Africa oligonucleotide synthesis market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oligonucleotide synthesis market will help companies and investors design strategic landscapes.
Services was the largest segment with a revenue share of 37.76% in 2024. Horizon Databook has segmented the South Africa oligonucleotide synthesis market based on oligonucleotides, equipment/synthesizer, reagents, services covering the revenue growth of each sub-segment from 2018 to 2030.
South Africa faces a significant burden of infectious diseases, such as HIV/AIDS and tuberculosis. Oligonucleotides are crucial in the R&D of diagnostics and therapeutics for these diseases. According to the Human Sciences Research Council, in 2022, approximately 7.8 million people were living with HIV in South Africa.
Furthermore, the increasing number of collaborations among healthcare organizations and companies is expected to accelerate market growth. For instance, in September 2021, BC Platforms and the African Institute of Everyone Genome (AiEG) strategically collaborated to develop a robust and integrated genomics data biobank in the African continent.
Reasons to subscribe to South Africa oligonucleotide synthesis market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Africa oligonucleotide synthesis market databook
-
Our clientele includes a mix of oligonucleotide synthesis market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa oligonucleotide synthesis market , including forecasts for subscribers. This country databook contains high-level insights into South Africa oligonucleotide synthesis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
South Africa oligonucleotide synthesis market size, by segment, 2018-2030 (US$M)
South Africa Oligonucleotide Synthesis Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
